331
Views
0
CrossRef citations to date
0
Altmetric
Original Article

May we use ibuprofen as doses against courses in the treatment of patent ductus arteriosus in premature infants?

, , , , , , & show all
Pages 1857-1860 | Received 04 Jun 2015, Accepted 23 Jun 2015, Published online: 13 Aug 2015

References

  • Hajjar ME, Vaksmann G, Rakza T. Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Foetal Neonatal Ed 2005;90:419–22
  • Clyman RI. Ibuprofen and patent ductus arteriosus. New Engl J Med 2000;343:728–39
  • Zonnenberg I, de Waal K. The definition of a haemodynamic significant duct in randomized controlled trials: a systematic literature review. Acta Paediatr 2012;101:247–51
  • Perlman JM, Hill A, Volpe JJ. The effect of patent ductus arteriosus on flow velocity in the anterior cerebral arterie: ductal steal in the premature newborn infants. J Pediatr 1981;99:767–71
  • Kluckow M, Evans N. Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 1995;127:774–9
  • Mercanti I, Boubred F, Simeoni U. Therapeutic closure of the ductus arteriosus: benefits and limitations. J Matern Fetal Neonatal Med 2009;22:14–20
  • Desfrere L, Zohar S, Morville P, et al. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method. J Clin Pharm Ther 2005;30:121–32
  • Abdel-Hady H, Nasef N, Shabaan A, Nour I. Patent ductus arteriosus in preterm infants: do we have the right answers? Biomed Res Int 2013;2013:676192
  • Ghanem S, Mostafa M, Shafee M. Effect of oral ibuprofen on patent ductus arteriosus in premature newborns. J Saudi Heart Assoc 2010;22:7–12
  • Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2013;4:CD003481
  • Uraş N, Ödemiş E, Kırmemiş Ö, et al. Treatment of PDA with enteral ibuprofen in preterm babies. N J Med 2007;24:164–7
  • Farstad T, Bratlid D. Pulmonary effects of closure of patent ductus arteriosus in premature infants with severe respiratory distress syndrome. Eur J Pediatr 1994;153:903–5
  • Ellison RC, Pecham GJ, Lang P, et al. Evaluation of the preterm infant for patent ductus arteriosus. Pediatrics 1983;71:364–72
  • Gokmen T, Erdeve O, Altug N, et al. Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus. J Pediatr 2011;158:549–54
  • Lin XZ, Chen HQ, Zheng Z, et al. Therapeutic effect of early administration of oral ibuprofen in very low birth weight infants with patent ductus arteriosus. Zhongguo Dang Dai Er Ke Za Zhi 2012;14:502–5
  • Bravo MC, Cabañas F, Riera J, et al. Randomised controlled clinical trial of standard versus echocardiographically guided ibuprofen treatment for patent ductus arteriosus in preterm infants: a pilot study. J Matern Fetal Neonatal Med 2014;27:904–9
  • Kushnir A, Pinheiro JM. Comparison of renal effects of ibuprofen versus indomethacin during treatment of patent ductus arteriosus in contiguous historical cohorts. BMC Clin Pharmacol 2011;11:8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.